Kala Pharmaceuticals Aktie (A3DWPS

Was macht Kala Pharmaceuticals?

Unternehmensprofil

KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Chart der Kala Pharmaceuticals Aktie

Charttool öffnen

Aktuelle Nachrichten zu Kala Pharmaceuticals

Weitere Nachrichten

Das berichten andere über Kala Pharmaceuticals

LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Kala Pharmaceuticals stock soars after settling $10.6M debt with Oxford Finance By Investing.com

Kala Pharmaceuticals stock soars after settling $10.6M debt with Oxford Finance

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to...

KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Tops Revenue Estimates

KalVista Pharmaceuticals (KALV) delivered earnings and revenue surprises of +4.17% and +242.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues...